Short-term and long-term results of robot-assisted cystectomy with various types of urine derivation in patients with urothelial carcinoma of the bladder

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Background. Cystectomy with various methods of urinary diversion remains the mainstay of treatment for patients with high-risk muscle-invasive and non-muscle-invasive bladder cancer (BC). The technical complexity and traumatic nature of this operation are the main reason for the high incidence of postoperative complications and mortality. One of the ways to reduce the morbidity of this intervention is the use of minimally invasive technologies, and robot-assisted operations are considered the most promising.

Objective. Analysis of our own experience of performing robot-assisted radical cystectomy using various methods of urine derivation.

Methods. The immediate and long-term results of treatment of 16 patients (15 men and 1 woman) with urothelial carcinoma of the bladder who underwent robot-assisted cystprostatvesiculectomy with various types of urine diversion were analyzed.

Results. The mean age of the patients was 64.6±9.0 years. The mean Charlson comorbidity index was 5±1. ECOG-0 – in 10, ECOG-1 – in 6 patients. The mean ASA score was 3. The mean body mass index was 26.0±8.1 kg/m2. Depending on the method of urine diversion, all patients were divided into 3 groups: I (n=7, 43.7%) – formation of an orthotopic urinary reservoir according to Studer, II (n=5, 31.3%) – creation of an ileoconduit according to Bricker, III (n=4, 25.0%) – bilateral ureterocutaneostomy. The average mean of the operation was 438±147 minutes (225–675 minutes), the mean blood loss was 304.2±173.8 ml (100–700 ml). Lymphadenectomy was performed in 11 patients. The average number of removed lymph nodes was 5. Metastases to the lymph nodes were detected in 3 patients (1 in each group). The number of lymph nodes affected by metastases was 1–3. Postoperative complications developed in 7 (43.8%) patients: grade II according to the Clavien-Dindo classification – in 3, grade IIIa – in 4. The mean bed-day was 24.8±6.0. Median follow-up was 20 months. Progression of the disease was observed in 2 (12.5%) patients.

Conclusion. The use of robot-assisted cystprostatvesiculectomy for surgical treatment of bladder cancer can reduce the morbidity of this surgical intervention, the frequency of early postoperative complications and achieve good oncological results.

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. Gritskevich

Vishnevsky National Medical Research Center for Surgery; Patrice Lumumba Peoples’ Friendship University of Russia

Хат алмасуға жауапты Автор.
Email: grekaa@mail.ru
ORCID iD: 0000-0002-5160-925X
SPIN-код: 2128-7536

Dr. Sci. (Med.), Head of the Department of Surgical Treatment of Urological Diseases, Professor of the Educational Department, Vishnevsky National Medical Research Center for Surgery; Professor at the Department of Urology and Operative Nephrology with a Course of Oncourology, Patrice Lumumba Peoples’ Friendship University of Russia

Ресей, Moscow; Moscow

V. Okhanyan

Vishnevsky National Medical Research Center for Surgery

Email: grekaa@mail.ru
ORCID iD: 0000-0002-2059-8703
Ресей, Moscow

D. Monakov

Vishnevsky National Medical Research Center for Surgery; Patrice Lumumba Peoples’ Friendship University of Russia

Email: grekaa@mail.ru
ORCID iD: 0000-0002-9676-1802
Ресей, Moscow; Moscow

A. Simonov

Vishnevsky National Medical Research Center for Surgery

Email: grekaa@mail.ru
ORCID iD: 0000-0003-3202-6873
Ресей, Moscow

A. Kochetov

Russian Biotechnological University; National Medical Research Center for High Medical Technologies – Vishnevsky Central Military Clinical Hospital

Email: grekaa@mail.ru
Ресей, Moscow; Moscow region, Krasnogorsk district

N. Karelskaya

Vishnevsky National Medical Research Center for Surgery

Email: grekaa@mail.ru
ORCID iD: 0000-0001-8723-8916
Ресей, Moscow

Zh. Polotbek

Vishnevsky National Medical Research Center for Surgery

Email: grekaa@mail.ru
ORCID iD: 0000-0002-2424-0493
Ресей, Moscow

I. Rusakov

Russian Society of Urological Oncology

Email: grekaa@mail.ru
Ресей, Moscow

Әдебиет тізімі

  1. Chang S.S., Bochner B.H., Chou R., et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017;198(3):552–59. doi: 10.1016/j.juro.2017.04.086.
  2. Chang S.S., Boorjian S.A., Chou R., et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO Guideline. J Urol. 2016;196(4):1021–29. doi: 10.1016/j.juro.2016.06.049.
  3. Katsimperis S., Tzelves L., Tandogdu Z., et al. Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis. Eur Urol Focus. 2023:S2405-4569(23)00113-X. doi: 10.1016/j.euf.2023.05.002.
  4. Hirobe M., Tanaka T., Shindo T., et al. Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan. Int J Clin Oncol. 2018;23(4):734–41. doi: 10.1007/s10147-018-1245-z.
  5. Грицкевич А.А., Байтман Т.П., Мирошкина И.В. и др. Возможности роботических технологий в лечении больных мышечно-инвазивным раком мочевого пузыря: робот-ассистированная цистэктомия обзор литературы. Экспериментальная и клиническая урология. 2021;14(2):30–9. [Gritskevich A.A., Baytman T.P., Miroshkina I.V. and others. Possibilities of robotic technologies in the treatment of patients with muscle-invasive bladder cancer: robot-assisted cystectomy, literature review. Eksperimental’naya i klinicheskaya urologiya. 2021;14(2):30–9. (In Russ.)]. doi: 10.29188/2222-8543-2021-14-2-32-39.
  6. Menon M., Hemal A.K., Tewari A., et al. Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina. J Am Coll Surg. 2004;198(3):386–93. doi: 10.1016/j.jamcollsurg.2003.11.010.
  7. Beecken W.D., Wolfram M., Engl T., et al. Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder. Eur Urol. 2003;44(3):337–39. doi: 10.1016/s0302-2838(03)00301-4.
  8. Parekh D.J., Reis I.M., Castle E.P., et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018;391(10139):2525–36. doi: 10.1016/S0140-6736(18)30996-6.
  9. Bochner B.H., Dalbagni G., Sjoberg D.D., et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur. Urol. 2015;67(6):1042–50. doi: 10.1016/j.eururo.2014.11.043.
  10. Клинические рекомендации Российского общества онкоурологов, Ассоциации онкологов России, Российского общества урологов, Российского общества клинической онкологии от 2022 г. «Рак мочевого пузыря». URL: https://oncology.ru/specialist/treatment/references/actual/11.pdf. Ссылка активна на 09.08.2023. [Clinical recommendations of the Russian Society of Urological Oncology, the Association of Russian Oncologists, the Russian Society of Urologists, the Russian Society of Clinical Oncology from 2022 “Bladder Cancer”. (In Russ.)]. URL: https://oncology.ru/specialist/treatment/references/actual/11.pdf. Link active as of 08/09/2023
  11. Gul Z.G., Katims A.B., Winoker J.S., et al. Robotic assisted radical cystectomy versus open radical cystectomy: a review of what we do and don’t know. Transl Androl Urol. 2021;10(5):2209–15. doi: 10.21037/tau.2019.11.32.
  12. Hussein A.A., May P.R., Jing Z., et al. Outcomes of intracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol. 2018;199(5):1302–11. doi: 10.1016/j.juro.2017.12.045.
  13. Грицкевич А.А., Мирошкина И.В., Байтман Т.П. и др. Робот-ассистированная полнослойная резекция при злокачественных опухолях мочевого пузыря. Онкология. Журнал им. П.А. Герцена. 2021;10(6):63–70. [Gritskevich A.A., Miroshkina I.V., Baytman T.P. et al. Robot-assisted full-thickness resection for malignant tumors of the bladder. Onkologiya. Zhurnal im. P.A. Gertsena. 2021;10(6):63–70. (In Russ.)]. doi: 10.17116/onkolog20211006163.
  14. Оганян В.А., Грицкевич А.А., Симонов А.Д. и др. Робот-ассистированная цистэктомия с ортотопической везикоплатикой при раке мочевого пузыря. Экспериментальная и клиническая урология 2022;(3):44–54. [Oganyan V.A., Gritskevich A.A., Simonov A.D. et al. Robot-assisted cystectomy with orthotopic vesicoplasty for bladder cancer. Experimental and Clinical Urology 2022;(3):44–54. (In Russ.)]. Doi: 10.291188/2222-8543-2022-15-3-44-54.
  15. Lee C.U., Kang M., Kim T.J., et al. Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion. Cancer Manag Res. 2019;11:5055–63. doi: 10.2147/CMAR.S199432.
  16. Wijburg C.J., Hannink G., Michels C.T.J., et al. Learning curve analysis for intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic Urology Section Scientific Working Group. Eur Urol Open Sci. 2022;39:55–61. doi: 10.1016/j.euros.2022.03.004.
  17. Chang S.S., Smith J.A., Wells N., et al. Estimated blood loss and transfusion requirements of radical cystectomy. J Urol. 2001;166(6):2151–54.
  18. Гулиев Б.Г., Комяков Б.К., Болокотов Р.Р., Аль-Аттар Т.Х. Робот-ассистированная радикальная цистэктомия с ортотопической деривацией мочи. Урология. 2020;(5):54–60. [Guliev B.G., Komyakov B.K., Bolokotov R.R., Al-Attar T.Kh. Robot-assisted radical cystectomy with orthotopic urinary diversion. Urology. 2020;(5):54–60. (In Russ.)]. doi: 10.18565/urology.2020.5.54-60.
  19. Гулиев Б.Г., Комяков Б.К., Болотоков Р.Р. Сравнительный анализ робот-ассистированной и открытой радикальной цистэктомии с ортотопической деривацией мочи. Урология. 2022;(4):15–22. [Guliev B.G., Komyakov B.K., Bolotokov R.R. Comparative analysis of robot-assisted and open radical cystectomy with orthotopic urinary diversion. Urology. 2022;(4):15–22. (In Russ.)]. doi: 10.18565/urology.2022.4.15-22.
  20. Павлов В.Н., М. Ф. Урманцев, М. Р. Бакеев Успехи робот-ассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыря. Онкоурология. 2022;18(2):123–28. [Pavlov V.N., M.F. Urmantsev, M.R. Bakeev Advances of robot-assisted cystectomy in the treatment of muscle-invasive bladder cancer. Oncourology. 2022;18(2):123–28. (In Russ.)]. doi: 10.17650/1726-9776-2022-18-2-123-128.
  21. Павлов В.Н., Сафиуллин Р.И., Урманцев М.Ф., Денейко А.С. Наш опыт выполнения робот-ассистированных радикальных цистэктомий с вариантами отведения мочи. Вопросы урологии и андрологии. 2020;8(4):47–8. [Pavlov V.N., Safiullin R.I., Urmantsev M.F., Deneyko A.S. Our experience in performing robot-assisted radical cystectomies with urinary diversion options. Voprosy urologii i andrologii. 2020;8(4):47–8. (In Russ.)].
  22. Зингеренко M.Б., Газарян М.А., Лахно Д.А., Мирзоев К.М. Радикальное хирургическое лечение инвазивного рака мочевого пузыря – робот-ассистированная цистэктомия. Московская медицина. 2017;S2:57–8. [Zingerenko M.B., Gazaryan M.A., Lakhno D.A., Mirzoev K.M. Radical surgical treatment of invasive bladder cancer is robot-assisted cystectomy. Moskovskaya meditsina. 2017;S2:57–8. (In Russ.)].
  23. Borghesi M., Schiavina R., Antonelli A., et al. Peri-operative outcomes after open and robot-assisted radical cystectomy by using an advanced bipolar seal and cut technology (Caiman®): a prospective, comparative, and multi-institutional study. Curr Urol. 2018;12:64–9. doi: 10.1159/000489421.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
2. Fig. 1. Number of RACE for 2020-2023, total and by methods of urine derivation

Жүктеу (116KB)
3. Fig. 2. Distribution of patients by study groups, %

Жүктеу (27KB)
4. Fig. 3. Distribution of patients by age groups, %

Жүктеу (36KB)
5. Fig. 4. Ilioobturator lymphadenectomy

Жүктеу (89KB)
6. Fig. 5. Formation of latero-lateral entero-entero anastomosis using a hardware suture

Жүктеу (94KB)
7. Fig. 6. Ureteral intubation with J-stents

Жүктеу (69KB)
8. Fig. 7. Stage of formation of a neoblader according to Studer’s method

Жүктеу (74KB)
9. Fig. 8. J-stents are brought out through the counteraperture in the apical part of the neoblader

Жүктеу (79KB)
10. Fig. 9. Neobladder relegated to the pelvis

Жүктеу (79KB)

© Bionika Media, 2023

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>